Reply to Li
et al
Am J Respir Crit Care Med
.
2023 Dec 1;208(11):1240-1241.
doi: 10.1164/rccm.202308-1418LE.
Authors
Lei Wang
1
2
,
Yang Cai
3
,
Johan Garssen
1
4
,
Paul A J Henricks
1
,
Gert Folkerts
1
,
Saskia Braber
1
Affiliations
1
Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands.
2
Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; and.
3
Department of Pharmacology, Jiangsu Provincial Key Laboratory of Critical Care Medicine, School of Medicine, Southeast University, Nanjing, China.
4
Danone Nutricia Research, Utrecht, The Netherlands.
PMID:
37672769
PMCID:
PMC10868346
DOI:
10.1164/rccm.202308-1418LE
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
Grants and funding
201706170055/Chinese Scholarship Council